ADNOVA CLINIC LIMITED
Opportunity 77/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (73/100).
Data confidence
Overall: high (80/100)Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · accounting standard not declaredKey financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-04-30 | 2024-04-30 |
|---|---|---|
| Total assets | £-1.10M | £-933.5k |
| Current assets | £210.3k | £215.9k |
| Cash | £98.8k | £124.8k |
| Debtors | £111.5k | £91.1k |
| Net assets | £-1.18M | £-1.08M |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
2 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
- • 1 officers
Corporate timeline (23 events)Click to expand
- 2026-01-23📄appoint-person-director-company-with-name-dateofficers · AP01
- 2025-12-06➕DURRANT, Marie-Noelle appointeddirector
- 2025-12-02📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-10-29📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-04-29📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-04-25📄change-account-reference-date-company-previous-shortenedaccounts · AA01
- 2024-04-22📄memorandum-articlesincorporation · MA
- 2024-04-22📄resolutionresolution · RESOLUTIONS
- 2024-01-30📄change-account-reference-date-company-previous-shortenedaccounts · AA01
- 2023-03-27📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-01-10📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2023-01-10📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2023-01-08📄capital-name-of-class-of-sharescapital · SH08
- 2022-06-01📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC05
- 2022-06-01📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2022-06-01📄capital-allotment-sharescapital · SH01
- 2021-04-15📄appoint-person-director-company-with-name-dateofficers · AP01
- 2021-04-15📄change-person-director-company-with-change-dateofficers · CH01
- 2021-04-14🏢Company incorporatedAs ADNOVA CLINIC LIMITED
- 2021-04-14➕DURRANT, Anthony appointeddirector
- 2021-04-14➕DURRANT, Charles Anthony Torlesse appointeddirector
- 2021-04-14➕HEPPELL, Philip Simon James appointeddirector
- 2021-04-14📄incorporation-companyincorporation · NEWINC
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- -4 active directors: Broader management team in place — suggests transferable governance.
- +Founder age: Director aged approximately 79 — succession pressure is live.
- +Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.
Succession & seller-readiness
Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.
- primaryFounder aged 70+: Senior director is approximately 79 years old. Natural succession window is now.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Charles Anthony Torlesse Durrant Individual · British · DOB 12/1973 · age 53 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 15/04/2022 |
2 historic (ceased) PSCs
- Charles Durrant Plastic Surgery Limitedceased 15/04/2022· 75-100% shares · 75-100% voting
- Mr Anothony Durrantceased 14/04/2022· 25-50% shares · 25-50% voting
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · SK postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A. FORSTER LIMITED→ 11154214 · est 2018 · no financials extracted | — | — | — | — | 8y | — | — |
| A&G ANAESTHETICS LIMITED→ 13147795 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| ABOUDI LIMITED→ 14855869 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AC SURGICAL LIMITED→ 16198147 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| ACADEMY FOR DENTISTS LIMITED→ 16567369 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ACHIEVE, INSPIRE AND MOTIVATE CIC→ 10157318 · est 2016 · no financials extracted | — | — | — | — | 9y | — | — |
| ACS (NORTH) LTD→ 11328297 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| AD HOC OCCUPATIONAL HEALTH LIMITED→ 09274809 · est 2014 · no financials extracted | — | — | — | — | 11y | — | — |
| ADHD SPECIALIST LIMITED→ 13821661 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| ADULT PSYCHOLOGICAL SOLUTIONS LTD→ 04882551 · est 2003 · no financials extracted | — | — | — | — | 22y | — | — |
| ADVANCED MSK SOLUTIONS LTD→ 16747036 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ADVANCED SKIN LIMITED→ 09885627 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (4 active · 0 resigned)
Click a director name to see their full track record across all companies.